
自引率: 2.9%
被引量: 5194
通过率: 暂无数据
审稿周期: 暂无数据
版面费用: 暂无数据
国人发稿量: 4
投稿须知/期刊简介:
Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1465-6566.<br><br>Expert Opinion on Pharmacotherapy (EOP) is published monthly (12 issues) in 2001, and is a unique source of peer-reviewed Drug Evaluations and Reviews. Expert Opinion on Pharmacotherapy is dedicated to the systematic evaluation and review of newly approved drugs and drug classes. Expert Opinion on Pharmacotherapy aims to provide comprehensive coverage of the emerging literature on and experience with newly approved compounds and an evaluated assessment of the likely impact of these new agents on existing pharmacotherapy of specific diseases. Expert Opinion on Pharmacotherapy focuses on new drugs and drug classes that have become available to the pharmacopoeia in the past 2 - 5 years, analysing their actual or presumptive effect on treatment guidelines. Expert Opinion on Pharmacotherapy adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.
期刊描述简介:
Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1465-6566. Expert Opinion on Pharmacotherapy (EOP) is published monthly (12 issues) in 2001, and is a unique source of peer-reviewed Drug Evaluations and Reviews. Expert Opinion on Pharmacotherapy is dedicated to the systematic evaluation and review of newly approved drugs and drug classes. Expert Opinion on Pharmacotherapy aims to provide comprehensive coverage of the emerging literature on and experience with newly approved compounds and an evaluated assessment of the likely impact of these new agents on existing pharmacotherapy of specific diseases. Expert Opinion on Pharmacotherapy focuses on new drugs and drug classes that have become available to the pharmacopoeia in the past 2 - 5 years, analysing their actual or presumptive effect on treatment guidelines. Expert Opinion on Pharmacotherapy adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.
-
Advances in pharmacotherapy for heart failure and reduced ejection fraction: what's new in 2024?
被引量:- 发表:1970
-
A systematic review on effect of sodium-glucose cotransporter-2 inhibitors on the metabolic and endocrinological profile of patients with polycystic ovarian syndrome.
被引量:- 发表:1970
-
Revisiting PPAR agonists: novel perspectives in the treatment of primary biliary cholangitis.
被引量:- 发表:1970
-
Emerging therapies for opioid-induced constipation: what can we expect?
被引量:- 发表:1970
-
Olezarsen, a liver-directed APOC3 ASO therapy for hypertriglyceridemia.
被引量:- 发表:1970